Lupin gets warning letter from USFDA for Mandideep facility

This is subsequent to an earlier intimation received from the United States Food and Drug Administration (USFDA) in March 2019 wherein the agency had classified its inspection conducted at the said facility in December 2018 as "official action indicated", Lupin said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/30wzLEy